Form 4: Joseph F. Lawler Acquires Stock Options in Anebulo Pharmaceuticals
SEC Form 4 Filing
Director Joseph F. Lawler reports acquisition of stock options in Anebulo Pharmaceuticals.
Summary
- Joseph F. Lawler, a director and 10% owner of Anebulo Pharmaceuticals, acquired stock options on April 4, 2025.
- Lawler acquired options to buy 25,000 shares and 13,236 shares of common stock at an exercise price of $1.02.
- The options vest on the earlier of April 4, 2026, or the date of the 2026 annual meeting of shareholders.
- Following the transaction, Lawler directly owns options for 38,236 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The acquisition of options by a director could be interpreted slightly positively, but it's not a major event.
Positives
- A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction provides shareholders with information about insider activity, which can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/04/2025 | Date of the stock option acquisition. |
| 04/04/2026 | Earliest vesting date for the stock options. |
| 04/03/2035 | Expiration date of the stock options. |
| 04/07/2025 | Date of the Form 4 filing. |
Keywords
stock options, Form 4, beneficial ownership, Anebulo Pharmaceuticals, Lawler, director, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.